ArcticZymes Technologies nominates Dr. Frank Mathias as new Chairman of the Board
TROMSØ, NORWAY: ArcticZymes Technologies (OSE:AZT) announced the nomination of Dr. Frank Mathias as the new Chairman of the Board. Dr. Mathias is the CEO at...
ArcticZymes Technologies divests Biotec BetaGlucans subsidiary to Lallemand
TROMSØ: ArcticZymes Technologies ASA (AZT) has today entered into a Share Purchase Agreement (SPA) with Lallemand Inc’s subsidiary, Danstar Ferment AG for the divestment of...
Biotec Pharmacon changes name to ArcticZymes Technologies
TROMSØ: Biotec Pharmacon announced it has officially rebranded to ArcticZymes Technologies. As previously announced and decided by the Annual General Meeting, Biotec Pharmacon ASA has...